Enovis Total Liabilities and Share Holders Equity 2010-2024 | ENOV
Enovis total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
| Enovis Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $4,719 |
| 2023 | $4,509 |
| 2022 | $4,273 |
| 2021 | $8,516 |
| 2020 | $7,352 |
| 2019 | $7,387 |
| 2018 | $6,616 |
| 2017 | $6,710 |
| 2016 | $6,338 |
| 2015 | $6,733 |
| 2014 | $7,212 |
| 2013 | $6,601 |
| 2012 | $6,148 |
| 2011 | $1,089 |
| 2010 | $1,022 |
| 2009 | $1,006 |
| Enovis Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $4,719 |
| 2024-09-30 | $5,550 |
| 2024-06-30 | $5,442 |
| 2024-03-31 | $5,479 |
| 2023-12-31 | $4,509 |
| 2023-09-30 | $4,401 |
| 2023-06-30 | $4,444 |
| 2023-03-31 | $4,300 |
| 2022-12-31 | $4,273 |
| 2022-09-30 | $4,445 |
| 2022-06-30 | $4,504 |
| 2022-03-31 | $8,484 |
| 2021-12-31 | $8,516 |
| 2021-09-30 | $7,972 |
| 2021-06-30 | $7,559 |
| 2021-03-31 | $8,067 |
| 2020-12-31 | $7,352 |
| 2020-09-30 | $7,154 |
| 2020-06-30 | $7,123 |
| 2020-03-31 | $7,456 |
| 2019-12-31 | $7,387 |
| 2019-09-30 | $9,591 |
| 2019-06-30 | $9,899 |
| 2019-03-31 | $10,502 |
| 2018-12-31 | $6,616 |
| 2018-09-30 | $6,446 |
| 2018-06-30 | $6,463 |
| 2018-03-31 | $6,879 |
| 2017-12-31 | $6,710 |
| 2017-09-30 | $6,838 |
| 2017-06-30 | $6,730 |
| 2017-03-31 | $6,430 |
| 2016-12-31 | $6,338 |
| 2016-09-30 | $6,542 |
| 2016-06-30 | $6,576 |
| 2016-03-31 | $6,724 |
| 2015-12-31 | $6,733 |
| 2015-09-30 | $7,040 |
| 2015-06-30 | $7,010 |
| 2015-03-31 | $6,945 |
| 2014-12-31 | $7,212 |
| 2014-09-30 | $7,529 |
| 2014-06-30 | $7,928 |
| 2014-03-31 | $6,771 |
| 2013-12-31 | $6,601 |
| 2013-09-30 | $6,334 |
| 2013-06-30 | $6,094 |
| 2013-03-31 | $5,846 |
| 2012-12-31 | $6,148 |
| 2012-09-30 | $6,056 |
| 2012-06-30 | $6,005 |
| 2012-03-31 | $6,130 |
| 2011-12-31 | $1,089 |
| 2011-09-30 | $1,039 |
| 2011-06-30 | $1,064 |
| 2011-03-31 | $1,062 |
| 2010-12-31 | $1,022 |
| 2010-09-30 | $1,004 |
| 2010-06-30 | $966 |
| 2010-03-31 | $989 |
| 2009-12-31 | $1,006 |
| 2009-09-30 | $1,025 |
| 2009-06-30 | $900 |
| 2009-03-31 | $889 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.475B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |